Biological features of the tumor (grading, microvascular or lymphatic invasion, alpha fetoprotein (AFP) level, and response to bridging therapies) also play an important role regarding HCC recurrence rates [17]. The gene discussed is AFP; the disease is hepatocellular carcinoma.